Summary of Use during Lactation

No information is available on the clinical use of pimavanserin during breastfeeding. If pimavanserin is required by the mother, it is not a reason to discontinue breastfeeding. However, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Effects in Breastfed Infants

Relevant published information was not found as of the revision date.

Effects on Lactation and Breastmilk

Relevant published information was not found as of the revision date.

Alternate Drugs to Consider

Haloperidol, Olanzapine, Quetiapine, Risperidone

Substance Name

Pimavanserin

CAS Registry Number

706779-91-1

Drug Class

Breast Feeding

Lactation

Milk, Human

Antiparkinson Agents

Antipsychotic Agents

Serotonin 5-HT2 Receptor Antagonists